tiprankstipranks
Advertisement
Advertisement

IRON Stock Latest News

Disc Medicine: Buy Rating Reiterated on Undervalued Hematology Pipeline, Upcoming Clinical Catalysts, and Unchanged $100 Price Target
RatingsDisc Medicine: Buy Rating Reiterated on Undervalued Hematology Pipeline, Upcoming Clinical Catalysts, and Unchanged $100 Price Target
9d ago
IRON
Disc Medicine price target raised to $90 from $85 at Morgan Stanley
PremiumThe Fly
Disc Medicine price target raised to $90 from $85 at Morgan Stanley
19d ago
IRON
Disc Medicine reports Q2 EPS ($1.54), consensus ($1.77)
PremiumThe Fly
Disc Medicine reports Q2 EPS ($1.54), consensus ($1.77)
1M ago
IRON
Disc Medicine Amends Loan Agreement, Expands Debt Capacity
PremiumCompany Announcements
Disc Medicine Amends Loan Agreement, Expands Debt Capacity
2M ago
8K
IRON
Disc Medicine Stockholders Approve Governance and Executive Pay
PremiumCompany Announcements
Disc Medicine Stockholders Approve Governance and Executive Pay
2M ago
8K
IRON
Disc Medicine price target raised to $85 from $80 at Morgan Stanley
PremiumThe FlyDisc Medicine price target raised to $85 from $80 at Morgan Stanley
3M ago
IRON
Disc Medicine Buy Rating Reiterated as APOLLO Phase III Progress and Bitopertin Outlook Support Unchanged $100 Price Target
Premium
Ratings
Disc Medicine Buy Rating Reiterated as APOLLO Phase III Progress and Bitopertin Outlook Support Unchanged $100 Price Target
3M ago
IRON
Disc Medicine: Outperform Rating Reiterated as Advancing Rare-Hematology Pipeline Supports Unchanged $100 Price Target
Premium
Ratings
Disc Medicine: Outperform Rating Reiterated as Advancing Rare-Hematology Pipeline Supports Unchanged $100 Price Target
3M ago
IRON
Disc Medicine presents updated data from RALLY-MF trial at ASCO
PremiumThe Fly
Disc Medicine presents updated data from RALLY-MF trial at ASCO
3M ago
IRON
Disc Medicine price target raised to $80 from $75 at Morgan Stanley
PremiumThe Fly
Disc Medicine price target raised to $80 from $75 at Morgan Stanley
4M ago
IRON
Disc Medicine reports Q1 EPS ($1.65), consensus ($1.73)
PremiumThe Fly
Disc Medicine reports Q1 EPS ($1.65), consensus ($1.73)
4M ago
IRON
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch
PremiumCompany Announcements
Disc Medicine Completes Key Phase 1b Study of DISC-0974 in CKD Anemia: What Investors Should Watch
5M ago
IRON
3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
5M ago
IRD
GENI
Disc Medicine completes enrollment in APOLLO trial
Premium
The Fly
Disc Medicine completes enrollment in APOLLO trial
5M ago
IRON
FDA review process for accelerated approval narrows, less predictable, WSJ says
Premium
The Fly
FDA review process for accelerated approval narrows, less predictable, WSJ says
6M ago
CAPR
IRON
Disc Medicine price target raised to $79 from $78 at Wells Fargo
PremiumThe Fly
Disc Medicine price target raised to $79 from $78 at Wells Fargo
6M ago
IRON
Disc Medicine Implements Restructuring Following FDA Response
PremiumCompany Announcements
Disc Medicine Implements Restructuring Following FDA Response
6M ago
8K
IRON
Disc Medicine price target lowered to $83 from $114 at Truist
PremiumThe Fly
Disc Medicine price target lowered to $83 from $114 at Truist
6M ago
IRON
Disc Medicine price target raised to $111 from $110 at Stifel
PremiumThe Fly
Disc Medicine price target raised to $111 from $110 at Stifel
6M ago
IRON
Disc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
PremiumRatingsDisc Medicine: Bitopertin’s De-Risked Path to Approval Supports Buy Rating
6M ago
IRON
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
Premium
Ratings
Disc Medicine: Strong Cash Runway and Bitopertin Upside Support Buy Rating Despite Regulatory Setbacks
6M ago
IRON
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
Premium
The Fly
Disc Medicine reports FY25 EPS ($6.01) vs ($3.96) last year
6M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >